The Claim

Early treatment with Nasodine within 24 hours of symptom onset reduces the Global Severity Score by 39.7% (p=0.024) in adults with common colds, indicating that timing is a critical factor for efficacy.

Source: Povidone-iodine nasal spray (Nasodine®) for the common cold: a randomized, controlled, double-blind, Phase III clinical trial

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
72score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

If you take Nasodine medicine soon after you start feeling sick with a cold, it can make your symptoms much less severe. Getting treated early is really important for it to work well.

See the scientific wording

Early treatment with Nasodine within 24 hours of symptom onset reduces Global Severity Score by 39.7% (p=0.024) in adults with common colds, highlighting timing as a critical factor for efficacy.

What the research says

1 study

  1. Study: Povidone-iodine nasal spray (Nasodine®) for the common cold: a randomized, controlled, double-blind, Phase III clinical trial

    The study tested the same nasal spray as the claim and found that using it early (within 24 hours) reduced cold symptoms by 39.7%, just like the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.